Abstract:Object High-grade meningiomas in childhood are rare, and their clinical features are unknown. The objective of this study was to determine the clinical characteristics and prognosis of childhood high-grade meningiomas. Methods Twenty-three patients with childhood high-grade meningiomas were treated at the Huashan Hospital. Clinical data were collected, tumor samples were reexamined, and prognoses were attained through follow-up visits and telephone interviews. Survival probability was calculated using the Kaplan-Meier method. A 2-sided probability level of 0.05 was chosen for statistical significance. Results The series included 18 males and 5 females (mean age 12.1 years). The most common symptoms were headache and vomiting (43%). Three patients had accompanying neurofibromatosis Type II (NF2). The high-grade meningioma cases with NF2 had larger tumor diameters than those without NF2 (p = 0.010). The skull base was the most common tumor site (39%). Complete resections were achieved in 11 patients after their initial operations. Adjuvant radiation therapy was performed in 9 cases. Follow-up evaluations were performed for 20 patients (mean follow-up 70 months). Ten patients experienced recurrences, 2 patients had lung metastases, and 7 patients died of the recurrence. The extent of surgery was significantly related to progression-free survival (PFS; p = 0.038). A negative progesterone receptor combined with strongly positive Bcl-2 immunoreactivity was significantly related to PFS (p = 0.001) and overall survival (p = 0.002). The MIB-1 labeling index was significantly related to overall survival (p = 0.018), whereas postoperative radiation therapy was not significantly related to PFS (p = 0.087) and overall survival (p = 0.40). Conclusions Childhood high-grade meningioma is a rare tumor type. Childhood high-grade meningioma has a male predominance and the basilar region is the most common tumor location. Patients with these tumors have high recurrence and mortality rates. The extent of resection is an important prognosis factor. A negative progesterone receptor combined with a strongly positive Bcl-2 immunoreaction might predict cancer recurrence. The MIB-1 labeling index correlates with the prognosis, and an MIB-1 labeling index > 3% increases the risk of recurrence in childhood high-grade meningioma. More cases should be collected, and longer follow-up periods should be obtained, to evaluate the effects of postoperative radiation therapy in childhood high-grade meningioma.

Microcystic Meningioma Has A Worse Outcome Than Other WHO Grade 1 Subtypes

Distinct Clinical Outcome of Microcystic Meningioma As a WHO Grade 1 Meningioma Subtype

Clinical Features and Prognostic Factors of Who Ii and Iii Adult Spinal Meningiomas: Analysis of 25 Cases in A Single Center

Clinical and Prognostic Features of Spinal Meningioma: a Thorough Analysis from a Single Neurosurgical Center.

Long Term Surgical Outcome and Prognostic Factors of Atypical and Malignant Meningiomas

Skull Base Atypical Meningioma: Long Term Surgical Outcome and Prognostic Factors.

Intracranial Clear Cell Meningioma: Clinical Study with Long-Term Follow-Up in 24 Patients.

Erratum: Clinical Features and Treatment of World Health Organization Grade II and III Meningiomas in Childhood: Report of 23 Cases.

Analysis of Prognostic Factors of World Health Organization Grade III Meningiomas

1245 Malignant Meningioma Survival, Recurrence and Functional Outcomes in an International Multicenter Cohort

Prognostic Factors for Patients with World Health Organization Grade III Meningiomas Treated at a Single Center

Long-term Outcome in Meningiomas Involving the Major Dural Sinuses with Combined Therapy of Subtotal Resection and Early Postoperative Gamma Knife Radiosurgery

Metastasis of World Health Organization Grade II and Grade III Meningiomas: Long-Term Survival and Associated Factor Analysis

Three Risk Factors for WHO Grade II and III Meningiomas: A Study of 1737 Cases from a Single Center.

Papillary Meningioma: an Aggressive Variant Meningioma with Clinical Features and Treatment: A Retrospective Study of 10 Cases

WHO Classification and Clinical Features of Meningiomas

Long-term Outcomes of Multimodality Management for Parasagittal Meningiomas

Analysis of Prognostic Factors and Treatment of Anaplastic Meningioma in China.

Intracranial Clear Cell Meningiomas: Study on Clinical Features and Predictors of Recurrence

Clinicopathological analysis of 845 intracranial meningiomas in a single institute

Papillary meningioma: clinical and histopathological observations.